DE3882599D1 - Hundecoronavirus-impfstoff. - Google Patents

Hundecoronavirus-impfstoff.

Info

Publication number
DE3882599D1
DE3882599D1 DE8888305190T DE3882599T DE3882599D1 DE 3882599 D1 DE3882599 D1 DE 3882599D1 DE 8888305190 T DE8888305190 T DE 8888305190T DE 3882599 T DE3882599 T DE 3882599T DE 3882599 D1 DE3882599 D1 DE 3882599D1
Authority
DE
Germany
Prior art keywords
ccv
vaccine
coronavirus vaccine
cell
dog coronavirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888305190T
Other languages
English (en)
Other versions
DE3882599T2 (de
Inventor
Michael Alonzo Gill
Stephen Wayne May
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Norden Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Laboratories Inc filed Critical Norden Laboratories Inc
Publication of DE3882599D1 publication Critical patent/DE3882599D1/de
Application granted granted Critical
Publication of DE3882599T2 publication Critical patent/DE3882599T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19883882599 1987-06-08 1988-06-07 Hundecoronavirus-Impfstoff. Expired - Fee Related DE3882599T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,437 US4904468A (en) 1987-06-08 1987-06-08 Canine coronavirus vaccine

Publications (2)

Publication Number Publication Date
DE3882599D1 true DE3882599D1 (de) 1993-09-02
DE3882599T2 DE3882599T2 (de) 1994-02-10

Family

ID=22022943

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19883882599 Expired - Fee Related DE3882599T2 (de) 1987-06-08 1988-06-07 Hundecoronavirus-Impfstoff.

Country Status (20)

Country Link
US (1) US4904468A (de)
EP (1) EP0295057B1 (de)
JP (1) JP2655876B2 (de)
KR (1) KR970000233B1 (de)
AT (1) ATE91902T1 (de)
AU (1) AU612151B2 (de)
CA (1) CA1337267C (de)
DE (1) DE3882599T2 (de)
DK (1) DK175410B1 (de)
ES (1) ES2058283T3 (de)
FI (1) FI87531C (de)
HU (1) HU203984B (de)
IE (1) IE63006B1 (de)
IL (1) IL86635A0 (de)
MY (1) MY103575A (de)
NO (1) NO176004C (de)
NZ (1) NZ224865A (de)
PH (1) PH27018A (de)
PT (1) PT87668B (de)
ZA (1) ZA884040B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
US5232694A (en) * 1989-05-03 1993-08-03 Akzo N.V. Canine corona virus vaccine
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
DE69128782T2 (de) * 1990-04-24 1998-09-10 Flustat Pty Ltd Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
US6372224B1 (en) * 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
PT510773E (pt) * 1991-04-25 2004-04-30 Akzo Nobel Nv Vacina subunidade do coronavirus canino
EP0524672A1 (de) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV-Impfstoff
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
EP0640098B1 (de) * 1992-05-08 2002-10-09 Pfizer Inc. Hundecoronavirus s gen und verwendung davon
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
ES2355702T3 (es) * 2005-10-26 2011-03-30 Canio Buonavoglia Coronavirus canino pantrópico.
US7761389B2 (en) 2007-08-23 2010-07-20 Gm Global Technology Operations, Inc. Method for anomaly prediction of battery parasitic load
JP2013507925A (ja) * 2009-10-14 2013-03-07 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ アライグマからのイヌパルボウイルス−２に関連するウイルスの分離
SG11201503854UA (en) 2012-11-22 2015-06-29 Asahi Kasei Medical Co Ltd Method for producing parvovirus having high infectivity titer
CN106290880B (zh) * 2015-05-27 2019-01-04 江苏雷森生物科技有限公司 一种用于犬冠状病毒的免疫层析用试剂组合物及检测方法
WO2017077804A1 (ja) 2015-11-06 2017-05-11 旭化成メディカル株式会社 高感染価かつ高純度のパルボウイルスの生産方法
CN110903387A (zh) * 2019-12-17 2020-03-24 吉林省纽卓莱生物科技有限责任公司 一种犬冠状病毒免疫球蛋白F(ab′)2及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
WO1986005806A1 (en) * 1985-03-29 1986-10-09 National Research Development Corporation Infectious bronchitis virus spike protein

Also Published As

Publication number Publication date
MY103575A (en) 1993-08-28
US4904468A (en) 1990-02-27
DK301588D0 (da) 1988-06-02
HU203984B (en) 1991-11-28
EP0295057B1 (de) 1993-07-28
IL86635A0 (en) 1988-11-30
PT87668B (pt) 1992-09-30
FI87531B (fi) 1992-10-15
IE63006B1 (en) 1995-03-22
KR970000233B1 (ko) 1997-01-08
JPS63316739A (ja) 1988-12-26
FI87531C (fi) 1993-01-25
EP0295057A3 (en) 1989-12-27
FI882689A (fi) 1988-12-09
HUT46858A (en) 1988-12-28
NO176004C (no) 1995-01-18
AU1747688A (en) 1988-12-08
NO176004B (no) 1994-10-10
ATE91902T1 (de) 1993-08-15
ES2058283T3 (es) 1994-11-01
KR890000105A (ko) 1989-03-11
PT87668A (pt) 1988-07-01
DK301588A (da) 1988-12-09
PH27018A (en) 1993-02-01
DK175410B1 (da) 2004-09-27
JP2655876B2 (ja) 1997-09-24
DE3882599T2 (de) 1994-02-10
FI882689A0 (fi) 1988-06-07
NZ224865A (en) 1990-12-21
CA1337267C (en) 1995-10-10
AU612151B2 (en) 1991-07-04
EP0295057A2 (de) 1988-12-14
NO882500D0 (no) 1988-06-07
NO882500L (no) 1988-12-09
IE881689L (en) 1988-12-08
ZA884040B (en) 1989-09-27

Similar Documents

Publication Publication Date Title
DE3882599D1 (de) Hundecoronavirus-impfstoff.
ES538588A0 (es) Un procedimiento para obtener una vacuna de coronavirus canino
DK0465204T3 (da) Vaccine mod Lyme sygdom
DK437980A (da) Felin infektioest peritonitis-virum og vacciner fremstillet deraf
ATE256746T1 (de) Subeinheits-impfstoff gegen hundecoronavirus
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
ATE109007T1 (de) Zellfreies marekskrankheitvirus-vakzin.
DE69210346T2 (de) Atmungskrankheitimpfstoff für Katzen
FI884521A0 (fi) Menetelmä rokotteen, joka suojaa kissoja kissojen tarttuvalta peritoniitilta, valmistamiseksi
DE68918649D1 (de) Lebende Newcastle-Krankheit-Virus-Vakzine.
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
ATE66818T1 (de) Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis.
ES2084587T3 (es) Arn virus no revertientes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PFIZER INC. (N.D.GES.D. STAATES DELAWARE), NEW YOR

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8339 Ceased/non-payment of the annual fee